Back to search

Article

Development of optimised human iPSC-derived hepatocytes with improved liver function for <i>in vitro</i> metabolic disease modelling and toxicity studies

2024-11-19

Abstract excerpt

<h4>Background & Aims</h4> Liver disease is a rising cause of mortality worldwide. Primary human hepatocytes (PHH) and hepatocellular cancer cells are currently used in drug development, however, they come with limitations, including limited supply, rapid loss of function, and tumorigenic origin. In addition, current iPSC differentiation protocols lead to the generation of hepatocyte-like cells with compromised l...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
94eedb2e-2752-518d-b1b9-40f7ffb813c1
DOI
10.1101/2024.11.18.624145
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of optimised human iPSC-derived hepatocytes with improved liver function for <i>in vitro</i> metabolic disease modelling and toxicity studiesDOI 10.1101/2024.11.18.624145
Select a neighboring publication to make it the new centre.